Lee S H, Caron N, Kimball A P
Cancer Res. 1977 Jul;37(7 Pt 1):1953-5.
Drug combinations of 9-beta-D-arabinofuranosyladenine and 2'-deoxycoformycin were active in the therapy of mice with intracerebral implants of the L1210 tumor. In in vivo mouse brain adenosine deaminase studies, inhibition of 9-beta-D-arabinofuranosyladenine deamination for periods of up to 24 hr was found after a single i.p. dose of 0.002 mmole/kg.
9-β-D-阿拉伯呋喃糖基腺嘌呤与2'-脱氧助间型霉素的药物组合对脑内植入L1210肿瘤的小鼠治疗有效。在体内小鼠脑腺苷脱氨酶研究中,腹腔注射单次剂量0.002毫摩尔/千克后,发现9-β-D-阿拉伯呋喃糖基腺嘌呤脱氨抑制长达24小时。